New Confidential Text Shows Draft Deal On UN Tuberculosis Declaration 05/09/2018 by David Branigan, Intellectual Property Watch 3 Comments A newly agreed draft text of the United Nations political declaration on tuberculosis was released to governments today, affirming the use of flexibilities in international trade rules on intellectual property, but excluding actionable language on those rules.
UN Tuberculosis Negotiations: What Is At Stake? 30/08/2018 by David Branigan, Intellectual Property Watch 2 Comments With negotiations over the final language of a United Nations high level declaration on ending tuberculosis still ongoing, the stakes are high as different TB stakeholders await the outcome. The language in question could either raise or reduce barriers to affordable access to life-saving TB drugs, according to civil society groups.
New Document On Traditional Knowledge, Folklore At WIPO; Chair Calls For New Conceptual Approach 30/08/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The protection of traditional knowledge and folklore against misappropriation is a topic that has been occupying World Intellectual Property Organization delegates for close to two decades. This week a new draft document, presenting a proposed revision of a set of draft articles of potential treaties, was released by a drafting team. As some countries are keen on preserving their original language and ideas, the committee chair called for delegates to move on with their work, and lift themselves above how the patent and copyright system works.
WIPO Traditional Knowledge Committee Begins Work On Core Issues; Indigenous Peoples May Be Left Out 27/08/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization’s committee seeking to find solutions against misappropriation of traditional knowledge opened this morning. While delegates are expected to negotiate wording of a potential treaty, the fund allowing indigenous peoples to participate in the discussions is empty with no foreseeable new donors, described by the chair as a historical situation. The committee is also trying to agree on recommendations for the upcoming WIPO General Assembly next month. On core issues, such as what the protection should cover, who would benefit from it, and under which conditions, delegates still have to find common positions.
Negotiators On UN TB Resolution May Have A Deal 23/08/2018 by William New and David Branigan, Intellectual Property Watch 23 Comments NEW YORK – Negotiators for a United Nations declaration on tuberculosis, meeting intensively in New York this week, may have reached agreement today on a key sticking point related to intellectual property, innovation and access to new medicines, according to sources. An agreement, if accepted by other delegations, could allow the text to proceed to the high-profile High-Level Meeting scheduled to take place at the UN General Assembly next month.
Wearable Tech: Intellectual Property Opportunities, Risks 23/08/2018 by David Branigan, Intellectual Property Watch Leave a Comment In wearable technology, product development converges with information and communication technology, presenting new opportunities for patents, as well as new risks, according to legal experts.
Can A Surge In Activism Defeat American Big Pharma? 22/08/2018 by Guest contributor for Intellectual Property Watch Leave a Comment By Vinayak Bhardwaj – Not a day passes in America without news of a drug company raising prices on prescription drugs. Americans pay two to six times more for prescription drugs than those living in other developed countries, who earn the same income.
Caso Truvada mostra o sucesso da sociedade civil com oposição a patentes 09/08/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment O exemplo do antiretroviral da Gilead, Truvada, no Brasil e Argentina mostram como os esforços da sociedade civil para contestar pedidos de patentes, que acreditavam ser injustos, foram recompensadas com arquivamento ou rejeição desses pedidos. No entanto, a situação no Brasil pode não estar inteiramente resolvida.
El caso de Truvada demuestra el éxito de la sociedad civil con la oposición anterior a la concesión de patentes 09/08/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment El ejemplo de Truvada, un medicamento antirretroviral de Gilead, en Argentina y Brasil demuestra que los esfuerzos desplegados por la sociedad civil para aplicar el procedimiento de oposición de patentes cuando las patentes se consideran injustificadas se vieron recompensados mediante el retiro y el rechazo de las patentes, aun si la situación en Brasil quizá no esté totalmente resuelta.
Truvada : quand la société civile s’oppose avec succès à l’octroi d’un brevet 09/08/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Certaines procédures d’opposition mises en œuvre par la société civile pour contester des brevets jugés injustifiés ont permis le rejet de demandes de brevets ou leur retrait. C’est le cas pour le Truvada, un antirétroviral du laboratoire Gilead, en Argentine et au Brésil, où la situation reste cependant susceptible d’évoluer.